96 related articles for article (PubMed ID: 8489766)
1. Comparison of growth and susceptibility testing of pyrazinamide in different Bactec media using strains of the M. tuberculosis complex.
Fuursted K
APMIS; 1993 Feb; 101(2):154-9. PubMed ID: 8489766
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of BACTEC MGIT 960 PZA medium for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide (PZA): compared with the results of pyrazinamidase assay and Kyokuto PZA test.
Aono A; Hirano K; Hamasaki S; Abe C
Diagn Microbiol Infect Dis; 2002 Dec; 44(4):347-52. PubMed ID: 12543539
[TBL] [Abstract][Full Text] [Related]
3. Rapid radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis.
Salfinger M; Reller LB; Demchuk B; Johnson ZT
Res Microbiol; 1989; 140(4-5):301-9. PubMed ID: 2508202
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.
Aragón LM; Garrigó M; Moreno C; Español M; Coll P
J Antimicrob Chemother; 2007 Sep; 60(3):655-7. PubMed ID: 17615155
[TBL] [Abstract][Full Text] [Related]
5. [Determination of pyrazinamide susceptibility for Mycobacterium tuberculosis by use of Middlebrook culture media and comparison with results of pyrazinamidase test].
Yamane N; Nakasone I; Yamashita K; Toyoda K; Okazawa Y
Rinsho Byori; 1998 May; 46(5):479-85. PubMed ID: 9627500
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis.
Tarrand JJ; Spicer AD; Gröschel DH
Antimicrob Agents Chemother; 1986 Dec; 30(6):852-5. PubMed ID: 3101586
[TBL] [Abstract][Full Text] [Related]
7. Pyrazinamide and pyrazinoic acid activity against tubercle bacilli in cultured human macrophages and in the BACTEC system.
Salfinger M; Crowle AJ; Reller LB
J Infect Dis; 1990 Jul; 162(1):201-7. PubMed ID: 2113074
[TBL] [Abstract][Full Text] [Related]
8. Differentiation among members of the Mycobacterium tuberculosis complex by molecular and biochemical features: evidence for two pyrazinamide-susceptible subtypes of M. bovis.
Niemann S; Richter E; Rüsch-Gerdes S
J Clin Microbiol; 2000 Jan; 38(1):152-7. PubMed ID: 10618079
[TBL] [Abstract][Full Text] [Related]
9. Esters of Pyrazinoic Acid Are Active against Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Other Naturally Resistant Mycobacteria In Vitro and Ex Vivo within Macrophages.
Pires D; Valente E; Simões MF; Carmo N; Testa B; Constantino L; Anes E
Antimicrob Agents Chemother; 2015 Dec; 59(12):7693-9. PubMed ID: 26438493
[TBL] [Abstract][Full Text] [Related]
10. Radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis in egg-yolk-enriched BACTEC 12A medium.
Woodley CL; Smithwick RW
Antimicrob Agents Chemother; 1988 Jan; 32(1):125-7. PubMed ID: 3126704
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the ESP and BACTEC systems for testing susceptibilities of Mycobacterium tuberculosis complex isolates to pyrazinamide.
LaBombardi VJ
J Clin Microbiol; 2002 Jun; 40(6):2238-9. PubMed ID: 12037096
[TBL] [Abstract][Full Text] [Related]
12. Long-Chain Fatty Acyl Coenzyme A Ligase FadD2 Mediates Intrinsic Pyrazinamide Resistance in Mycobacterium tuberculosis.
Rosen BC; Dillon NA; Peterson ND; Minato Y; Baughn AD
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855077
[TBL] [Abstract][Full Text] [Related]
13. Pyrazinamide susceptibility testing in Mycobacterium tuberculosis using the fast resazurin microtiter assay plate.
Pina RZ; Caleffi-Ferracioli KR; Campanerut-Sá PA; Ghiraldi-Lopez LD; Pavan FR; Siqueira VL; Scodro RB; Cardoso RF
Int J Tuberc Lung Dis; 2016 Nov; 20(11):1535-1538. PubMed ID: 27776597
[TBL] [Abstract][Full Text] [Related]
14. Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide: comparison of Bactec method with pyrazinamidase assay.
Miller MA; Thibert L; Desjardins F; Siddiqi SH; Dascal A
J Clin Microbiol; 1995 Sep; 33(9):2468-70. PubMed ID: 7494049
[TBL] [Abstract][Full Text] [Related]
15. [Pyrazinamide monoresistant Mycobacterium tuberculosis in Manisa region, Turkey].
Ozkütük N; Ecemiş T; Sürücüoğlu S
Mikrobiyol Bul; 2008 Oct; 42(4):585-90. PubMed ID: 19149079
[TBL] [Abstract][Full Text] [Related]
16. New agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide.
Heifets L; Sanchez T
J Clin Microbiol; 2000 Apr; 38(4):1498-501. PubMed ID: 10747133
[TBL] [Abstract][Full Text] [Related]
17. Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide with the nonradiometric BACTEC MGIT 960 system.
Pfyffer GE; Palicova F; Rüsch-Gerdes S
J Clin Microbiol; 2002 May; 40(5):1670-4. PubMed ID: 11980940
[TBL] [Abstract][Full Text] [Related]
18. Estimation of pyrazinamidase activity using a cell-free
Rueda D; Bernard C; Gandy L; Capton E; Boudjelloul R; Brossier F; Veziris N; Zimic M; Sougakoff W
Int J Mycobacteriol; 2018; 7(1):16-25. PubMed ID: 29516881
[TBL] [Abstract][Full Text] [Related]
19. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Turkey.
Yüksel P; Tansel O
New Microbiol; 2009 Apr; 32(2):153-8. PubMed ID: 19579692
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of Mycobacterium tuberculosis by polyoxyethylene stearate present in the BACTEC pyrazinamide susceptibility test.
Miller MA; Thibert L; Desjardins F; Siddiqi SH; Dascal A
J Clin Microbiol; 1996 Jan; 34(1):84-6. PubMed ID: 8748279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
